​Astellas Partners with Kate Therapeutics in Gene Therapy, After Four Patient Deaths in Previous Trials

Astellas Pharma will license and further develop a gene therapy from Kate Therapeutics aimed at addressing XLMTM amid safety concerns about its own experimental XLMTM treatment.